Clinical Trials Browser

Recruiting × Peripheral Nervous System Diseases × 90 days × Clear all

Peripheral Nervous System Diseases

NCT07484022 2026-06-03

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Phase 1 Recruiting

37 enrolled

Genitourinary

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT06848348 2026-05-29

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Phase 2 Recruiting

240 enrolled

BreastGastrointestinal

Cancer Pain, Breast Neoplasms, Neoplasms, Neuralgia, Pain, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT07109817 2026-05-29

DETOXp

Phase 2 Recruiting

116 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05404230 2026-05-19

OxaNeuro

Phase NA Recruiting

120 enrolled

Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT05104736 2026-05-12

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Recruiting

53 enrolled

Thoracic

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT07501663 2026-04-14

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

Phase NA Recruiting

60 enrolled

Peripheral Nervous System Diseases

NCT05990426 2026-03-24

FAST

Phase NA Recruiting

30 enrolled

Gynecologic

Intermittent Fasting, Ovarian Neoplasms, Peripheral Nervous System Diseases, Uterine Neoplasms, Endometrial Neoplasms

Clinical Trials

EX-CIPN

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

DETOXp

OxaNeuro

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

FAST